Maria Anastasiou

7PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Evaluation of Longitudinal CD40 and CD40L Changes During Adjuvant Breast Cancer Therapy and Their Association with Left Ventricular Dysfunction.

|Feb 27, 2026
Correction: Anastasiou et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908.

Maria Anastasiou, Evangelos Oikonomou, Panagiotis Theofilis

|Dec 31, 2025
MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients.

Maria Anastasiou, Evangelos Oikonomou, Panagiotis Theofilis

|Oct 29, 2025
The Role of miRNAs in Chemotherapy-Induced Cardiotoxicity.

Maria Anastasiou, Evangelos Oikonomou, Panagiotis Theofilis

|Aug 14, 2023
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.

Myrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis

|Apr 14, 2023
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma.

Niki Gavrielatou, Ioannis Vathiotis, Thazin Nwe Aung

Pageof 2

Frequent Collaborators

4 joint publications

Evangelos Oikonomou

4 joint publications

Panagiotis Theofilis

4 joint publications

Maria Gazouli

3 joint publications

Panagiota Economopoulou